Edition:
United States

Nanovibronix Inc (NAOV.OQ)

NAOV.OQ on NASDAQ Stock Exchange Capital Market

4.36USD
4:00pm EDT
Change (% chg)

$0.13 (+3.07%)
Prev Close
$4.23
Open
$4.20
Day's High
$4.36
Day's Low
$4.20
Volume
103
Avg. Vol
2,769
52-wk High
$5.00
52-wk Low
$3.68

Latest Key Developments (Source: Significant Developments)

Nanovibronix Enters Agreement For Distribution Of Painshield And Woundshield In Israel
Tuesday, 5 Jun 2018 07:00am EDT 

June 5 (Reuters) - NanoVibronix Inc ::NANOVIBRONIX ANNOUNCES EXCLUSIVE AGREEMENT FOR DISTRIBUTION OF PAINSHIELD® AND WOUNDSHIELD® IN ISRAEL.NANOVIBRONIX INC - ENTERED EXCLUSIVE AGREEMENT WITH M.D.S. PHARM LTD. TO MARKET AND DISTRIBUTE NANOVIBRONIX'S PAINSHIELD AND WOUNDSHIELD IN ISRAEL.  Full Article

Nanovibronix Signs Instrumed Surgical As Exclusive Distributor For UroShield Products In Canada
Thursday, 5 Apr 2018 07:30am EDT 

April 5 (Reuters) - NanoVibronix Inc ::NANOVIBRONIX INC - SIGNED INSTRUMED SURGICAL OF MISSISSAUGA, ONTARIO, CANADA AS ITS EXCLUSIVE DISTRIBUTOR FOR UROSHIELD PRODUCTS IN CANADA.  Full Article

Nanovibronix Inc - Signed Morulaa Healthtech As Its Regulatory And Marketing Partner In India
Wednesday, 20 Dec 2017 09:00am EST 

Dec 20 (Reuters) - Nanovibronix Inc ::NANOVIBRONIX INC - SIGNED MORULAA HEALTHTECH AS ITS REGULATORY AND MARKETING PARTNER IN INDIA.  Full Article

Nanovibronix Announces Exclusive U.K. Distributor For Painshield
Tuesday, 5 Dec 2017 08:00am EST 

Dec 5 (Reuters) - Nanovibronix Inc ::NANOVIBRONIX ANNOUNCES EXCLUSIVE UK DISTRIBUTOR FOR PAINSHIELD(TM) PROVIDING PATIENTS AN ALTERNATIVE TO OPIOIDS AND SURGERY.SAYS ‍IT HAS SIGNED BHR PHARMACEUTICALS LTD AS ITS EXCLUSIVE DISTRIBUTOR FOR PAINSHIELD IN UNITED KINGDOM​.  Full Article

Nanovibronix ‍Expects To Complete Trial For Use Of Painshield In Patients With Trigeminal Neuralgia In Q1 Of 2018​
Wednesday, 29 Nov 2017 07:30am EST 

Nov 29 (Reuters) - Nanovibronix Inc ::NANOVIBRONIX REPORTS SUCCESSFUL INTERIM TRIAL RESULTS FOR USE OF PAINSHIELD(TM) IN PATIENTS WITH TRIGEMINAL NEURALGIA; REPRESENTS POTENTIAL ALTERNATIVE TO OPIOID AND SURGICAL INTERVENTIONS.NANOVIBRONIX INC - ‍EXPECTS TO COMPLETE TRIAL FOR USE OF PAINSHIELD IN PATIENTS WITH TRIGEMINAL NEURALGIA IN Q1 OF 2018​.  Full Article

Nanovibronix Inc to commence trial of anti-aging device
Tuesday, 14 Nov 2017 07:50am EST 

Nov 14 (Reuters) - Nanovibronix Inc :Nanovibronix to commence trial of anti-aging device in collaboration with a global cosmetics company.Execution of collaborative agreement to conduct a single-center clinical trial in conjunction with a global cosmetics company​.Following trial, the two companies plan to explore further collaboration opportunities​.  Full Article

BRIEF-Nanovibronix Signs Instrumed Surgical As Exclusive Distributor For UroShield Products In Canada

* NANOVIBRONIX INC - SIGNED INSTRUMED SURGICAL OF MISSISSAUGA, ONTARIO, CANADA AS ITS EXCLUSIVE DISTRIBUTOR FOR UROSHIELD PRODUCTS IN CANADA Source text for Eikon: Further company coverage: